Description
Phase
Phase 2 - takes the treatment one step further, assessing the activity of a particular therapy in a disease, often building upon leads from the Phase I trial. While patients are generally required to be previously untreated, participation in a Phase II trial doesn't usually preclude the patient from getting the standard treatment after they've received the investigational agent. At best they are allowed to get a new drug they wouldn't be able to get otherwise that may turn out to be better for their disease.Inclusion and Exclusion Criteria
Please contact the trial administrator to learn more about the eligibility criteria for this trial. Please use the contact form on the right side.
Sites
-
Nevada
- Comprehensive Cancer Center Of Nevada, Las Vegas, Nevada, 89148
-
Colorado
- Rocky Mountain Cancer Centers, Aurora, Colorado, 80012
-
Kansas
- Cancer Center Of Kansas, Wichita, Kansas, 67214
-
Texas
- Texas Oncology Sammons Cancer Center, Dallas, Texas, 75246
-
Alabama
- Birmingham Hematology & Oncology Associates Llc, Birmingham, Alabama, 35205
-
Indiana
- Investigative Clinical Research Of Indiana, Llc, Indianapolis, Indiana, 46260
-
France
- Local Institution, Paris, 75010
-
Germany
- Local Institution, Tubingen, 72076
- Local Institution, Goettingen, 37075
Powered by
SC CTSI